News
Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...
A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...
More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...
Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...
With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...
The Independent on MSN5h
Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drugNovo Nordisk has announced it is ending its distribution collaboration with US telehealth firm Hims & Hers Health over the ...
Weight loss jab could be used to treat migraines. GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines ...
Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who ...
Gone are the days of battling obesity with a limited toolbox. With more weight loss supplements and drugs on the market than ever before, deciding which medication is right for you isn' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results